Publication number: 20090117641
Abstract: The present invention relates to isolated polypeptides which comprise a functional kinase domain comprising the amino acid sequence of the native human Abl kinase domain or an essentially similar sequence thereof in which at least one amino acid selected from Met244, Leu248, Gly250, Glu252, Tyr253, Val256, Glu258, Phe311, Ile313, Phe317, Met318, Met351, Glu355, Glu359, Ile360, His361, Leu370, Asp381, Phe382, His396, Ser417, Glu459 and Phe486 is replaced by another amino acid, said mutated functional kinase domain being resistant to inhibition of its tyrosine kinase activity by N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide or a salt thereof, to the use of such polypeptides to screen for compounds which inhibit the tyrosine kinase activity of such polypeptides, to nucleic acid molecules encoding such polypeptides, to recombinant vectors and host cells comprising such nucleic acid molecules and to the use of such nucleic acid molecules in the production of
Type:
Application
Filed:
June 30, 2008
Publication date:
May 7, 2009
Inventors:
Christophe Barthe, Susan Bradford, Amie Corbin, Brian Jay Druker, Justus Duyster, Andreas Hochhaus, Timothy Hughes, Sebastian Kreil, Thibaut Leguay, Francios-Xavier Mahon, Gerald Marit, Martin Muller, Christian Peschel, Claude Preudhomme, Catherine Roche Lestienne, Zbigniew Rudzki
Publication number: 20090099282
Abstract: The present invention discloses functionalized nanoparticles comprising on the surface a covalently bound radical of formula (1), wherein the nanoparticles are SiO2, Al2O3 or mixed SiO2 and Al2O3 nanoparticles, R1 and R2 are independently of each other hydrogen, nanoparticle surface-O—, or a substituent, n is 1, 2, 3, 4, 5, 6, 7 or 8, and Y is a radical of formula —B1-D1 (2a), wherein B1 is the direct bond or a bridge member, and D1 is a radical of a cationic dye, a radical of a phthalocyanine dye which carries no water-solubilizing group, or a radical of a fluorescent dye selected from the group consisting of coumarins, benzocoumarins, xanthenes, benzo[a]xanthenes, benzo[b]xanthenes, benzo[c]xanthenes, phenoxazines, benzo[a]phenoxazines, benzo[b]phenoxazines, benzo[c]phenoxazines, napthalimides, naphtholactams, azlactones, methines, oxazines, thiazines, diketopyrrolopyrroles, quinacridones, benzoxanthenes, thio-epindolines, lactamimides, diphenylmaleimides, acetoacetamides, imidazothiazines, benzanthrones, p
Type:
Application
Filed:
May 17, 2006
Publication date:
April 16, 2009
Inventors:
Martin Muller, Andreas Muhlebach, Thomas Giesenberg, Didier Bauer, Thomas Ruch, Francois Rime, Leonhard Feiler, Roman Lenz, Laurent Michau